Variability of lipoprotein-associated phospholipase A2 measurements

Clinical Chemistry

Volumn 54, Issue 5, 2008, Pages 932-933

  McConnell, Joseph P ^a   Jaffe, Allan S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BIOLOGICAL MARKER;

DRESSLER SYNDROME; FOOD AND DRUG ADMINISTRATION; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOASSAY; INFLAMMATION; ISCHEMIC HEART DISEASE; LABORATORY TEST; LETTER; MEDICAL INSTRUMENTATION; PROTEIN ANALYSIS; PROTEIN VARIANT; STROKE;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AUTOANALYSIS; BIOLOGICAL MARKERS; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; QUALITY CONTROL; REAGENT KITS, DIAGNOSTIC; STROKE;

EID: 43449090390     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2008.103358     Document Type: Letter

References (4)

1. Khuseyinova N, Greven S, Rückerl R, Trischler G, Loewel H, Peters A, Koenig W. Variability of serial lipoprotein-associated phospholipase A2 measurements in post-myocardial infarction patients: results form the AIRGENE Study Center Augsburg. Clin Chem 2008;54:124-30.
2. McConnell JP, Hoefner DM. Lipoprotein-associated phospholipase A(2). Clin Lab Med 2006;26:679-97.
3. Caslake MJ, Packard CJ. Lipoprotein-associated phospholipase A2 as a biomarker for coronary disease and stroke. Nat Clin Pract Cardiovasc Med 2005;2:529-35.
4. Carlquist JF, Muhlestein JB, Anderson JL. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Expert Rev Mol Diagn 2007;7:511-7.